Chemours officer reports 3,500 shares on Form 3

Chemours Co officer Michael Robert Foley filed an initial statement of beneficial ownership as of February 4, 2026.

Accepted by SEC EDGAR 02/13/2026 - 05:00 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Chemours Co officer Michael Robert Foley filed an initial statement of beneficial ownership as of February 4, 2026. He reported holding 3,500 shares of Chemours common stock in direct ownership. Foley is identified with the title President, Titanium Technologies, and no derivative securities were listed.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Foley Michael Robert

Role See Remarks

Type	Security	Shares	Price	Value
Holding	Common Stock	--	--	--

Holdings: Common Stock — 3,500 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Chemours (CC) Form 3 filed by Michael Robert Foley show?

The Form 3 shows that officer Michael Robert Foley beneficially owns 3,500 shares of Chemours common stock. The filing is an initial ownership report, indicating his direct holdings when he became a reporting insider on February 4, 2026.

How many Chemours (CC) shares does Michael Robert Foley report owning?

Michael Robert Foley reports owning 3,500 shares of Chemours common stock. The shares are listed as directly held, meaning they are not reported through a trust or other intermediary entity in this filing.

What is Michael Robert Foley’s role at Chemours (CC) in this Form 3?

In the Form 3, Michael Robert Foley is identified as an officer of Chemours with the title President, Titanium Technologies. This title appears in the remarks section and establishes his status as a company insider subject to reporting rules.

Does the Chemours (CC) Form 3 report any recent stock transactions by Foley?

The Form 3 functions as an initial ownership report and does not show specific buy or sell transactions. It instead discloses Foley’s beneficial ownership position of 3,500 Chemours common shares following the reported date of February 4, 2026.

Are Michael Robert Foley’s Chemours (CC) shares held directly or indirectly?

The Form 3 lists Foley’s 3,500 Chemours common shares as directly owned, marked with ownership code “D.” No indirect ownership entities or nature of indirect beneficial ownership are specified in the filing’s ownership table.

Does Michael Robert Foley report any derivative securities of Chemours (CC)?

The Form 3 includes a table for derivative securities but shows no entries for options, warrants, or other derivatives. Only non-derivative common stock holdings of 3,500 directly owned shares are disclosed in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Foley Michael Robert

(Last) (First) (Middle)

1007 MARKET STREET

(Street)

WILMINGTON DE 19801

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/04/2026

3. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	3,500	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Power of Attorney attached as Exhibit 24 Title: President, Titanium Technologies

	/s/ Eric Stein, Attorney-in-Fact	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.